Dasatinib plus Quercetin
Sponsors
St. Jude Children's Research Hospital, TruDiagnostic
Conditions
AgingChildhood CancerFrailty
Phase 2
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
Active, not recruitingNCT04733534
Start: 2022-06-06End: 2027-12-01Updated: 2026-04-24
Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging
NCT04946383
Start: 2020-12-16End: 2022-06-30Target: 25Updated: 2021-08-03